Excelsia Inc’s GSK GSK Stock Holding History

Excelsia Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$694K	Buy	13,321 +247	+2%	+$13.9K	1.46%	14
2015 Q1	$754K	Buy	13,074 +507	+4%	+$29.1K	1.45%	20
2014 Q4	$671K	Buy	12,567 +379	+3%	+$21.2K	1.57%	24
2014 Q3	$700K	Sell	12,188 -916	-7%	-$56.2K	1.16%	32
2014 Q2	$876K	Buy	13,104 +200	+2%	+$13.5K	1.12%	35
2014 Q1	$862K	Sell	12,904 -728	-5%	-$49.2K	1.2%	33
2013 Q4	$910K	Sell	13,632 -1,328	-9%	-$86.1K	1.26%	33
2013 Q3	$938K	Sell	14,960 -1,824	-11%	-$117K	1.01%	33
2013 Q2	$1.05M	Buy	+16,784	New	+$1.07M	1.02%	35

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Excelsia Inc's GSK Position: Q2 2015 in Review

Excelsia Inc increased its GSK (GSK) stake by 1.9% in Q2 2015, buying an estimated $13.9K and bringing the position to 13,321 shares worth $694K. The position accounts for 1.46% of the portfolio, ranked #14.

Excelsia Inc first reported a position in GSK in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.05M in Q2 2013. 720 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

Excelsia Inc held 13,321 shares of GSK worth $694K as of Q2 2015.
Excelsia Inc bought 247 GSK shares in Q2 2015, an estimated $13.9K.
GSK made up 1.46% of Excelsia Inc's portfolio in Q2 2015, its #14 holding.
Excelsia Inc first reported a position in GSK in Q2 2013 and has held it in 9 quarters since.
Excelsia Inc's GSK position peaked at $1.05M in Q2 2013.
720 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Excelsia Inc's 13F filing for Q2 2015, filed 29 Jul 2015.